Goetz Schlotterbeck

Title: Goetz Schlotterbeck: Innovator in Biomarker and Spectral Processing Technologies

Introduction

Goetz Schlotterbeck is a notable inventor based in Efringen-Kirchen, Germany. He has made significant contributions to the fields of biomarker development and spectral processing. With a total of 2 patents, Schlotterbeck's work has the potential to impact various scientific and medical applications.

Latest Patents

One of Schlotterbeck's latest patents is focused on a biomarker for the farnesyl pathway. This invention provides methods to determine the extent to which a compound interferes with steroid metabolism, featuring a novel biomarker derived from felinine. Additionally, he has developed a method for processing a set of spectra, particularly NMR spectra. This method involves selecting a principal spectral range, recording multiple principal spectra, and conducting statistical analyses to detect outliers.

Career Highlights

Goetz Schlotterbeck is currently associated with Hoffmann-La Roche Inc., where he applies his expertise in innovative research and development. His work has contributed to advancements in understanding complex biochemical processes and improving analytical techniques.

Collaborations

Throughout his career, Schlotterbeck has collaborated with esteemed colleagues such as Frank Dieterle and Hans Senn. These partnerships have fostered a collaborative environment that enhances the quality and impact of their research.

Conclusion

Goetz Schlotterbeck's innovative contributions to biomarker and spectral processing technologies highlight his role as a significant figure in scientific research. His patents reflect a commitment to advancing knowledge in these critical areas.